Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-18

FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for Nurtec ODT (rimegepant sulfate) from Pfizer Laboratories Div Pfizer Inc, updating the drug's labeling as part of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

SUPPL AP for NURTEC ODT (RIMEGEPANT SULFATE)